Welcome to
RBP World!
Drugs target to HSPB1
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| APATORSEN | Oligonucleotide | pancreatic carcinoma | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 2.0 | Completed | ClinicalTrials |
| APATORSEN | Oligonucleotide | neoplasm | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 1.0 | Completed | ClinicalTrials |
| APATORSEN | Oligonucleotide | squamous cell lung carcinoma | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 2.0 | Unknown status | ClinicalTrials |
| APATORSEN | Oligonucleotide | prostate cancer | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 2.0 | Terminated | ClinicalTrials |
| APATORSEN | Oligonucleotide | urinary bladder cancer | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 1.0 | Unknown status | ClinicalTrials |
| APATORSEN | Oligonucleotide | non-small cell lung carcinoma | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 2.0 | Completed | ClinicalTrials |
| APATORSEN | Oligonucleotide | prostate cancer | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor | 2.0 | Completed | ClinicalTrials |